Clinical Trial Update: Placebo-Controlled Randomized Study of KW-3902 for Subjects Hospitalized With Worsening Renal Function and Heart Failure Requiring IV Therapy [Phase 3]

View source ↗

Summary

Phase 3 placebo-controlled randomized study of KW-3902 in hospitalized patients with worsening renal function and heart failure requiring IV therapy has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Renal Failure

Drugs mentioned

• KW-3902

Snippet

Sponsor: NovaCardia, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Conditions: Heart Failure, Congestive | Phase 3 | Status: COMPLETED